The Instituto Nacional de Higiene Rafael Rangel issued two urgent health alerts regarding the distribution of counterfeit 5% hyperbaric Cifarcaina and clandestine injectable peptides across Venezuela.
- Spotting Counterfeits: The fake anesthetic lot features amber glass instead of clear vials, inverted labels, and missing protective packaging.
- Unregulated Risks: Clandestine peptides sold online lack sterility and traceability, posing direct threats of infection or toxicity.
Health authorities published alert N.° ALSA-PE-2026-016 after uncovering widespread falsification of Cifarcaina Hyperbarica 5% solution for injection. Laboratorio Behrens, C.A. holds the legitimate manufacturing rights for the medication within the country. Investigators identified the irregularities specifically within batch 2500130, which bears a manufacturing date of May 2025 and an expiration date set for May 2028.
The manufacturing firm noted severe physical discrepancies on the illicit packaging. Counterfeit units utilized amber glass ampoules rather than the standard transparent and colorless presentation. Inspectors found typographical errors in the printing, inverted product labels, and a complete absence of the protective outer case.
In a separate warning under alert N.° ALSA-PE-2026-015, regulatory officials highlighted the unauthorized commercialization of injectable peptides and analogues. These substances circulate in multiple vials completely devoid of official sanitary registration or regulatory approval. Vendors promote and distribute these unverified formulas primarily through digital platforms and social media networks.
The absence of proper supply chain tracking, sterilization protocols, and storage temperature controls invalidates any assurance of therapeutic efficacy. Health officials categorize the circulation of these unverified chemical agents as an imminent danger to public health and consumer safety.
| Product Name | Alert Identifier | Identified Irregularity |
|---|---|---|
| Cifarcaina Hiperbarica 5% | ALSA-PE-2026-016 (Batch 2500130) | Amber glass instead of clear, inverted labels, typographical errors. |
| Injectable Peptides and Analogues | ALSA-PE-2026-015 | No sanitary registration, sold via social media, missing sterility controls. |
Individuals utilizing injectable peptides purchased from unverified online vendors should halt administration without delay to prevent adverse pharmacological reactions. Anyone experiencing unexpected physiological symptoms following an injection should consult a qualified medical professional immediately and report suspicious drug distribution to health authorities.
Regulatory agencies instruct citizens to avoid acquiring any pharmaceutical product via social media, unauthorized websites, or informal storefronts.
- Instituto Nacional de Higiene Rafael Rangel (INHRR) – Official Sanitary Alert N.° ALSA-PE-2026-016
- Instituto Nacional de Higiene Rafael Rangel (INHRR) – Official Sanitary Alert N.° ALSA-PE-2026-015
- Ministerio del Poder Popular para la Salud – Public Health Regulatory Directives
